NB 003Alternative Names: NB-003
Latest Information Update: 07 Jan 2016
At a glance
- Originator NanoBio Corporation
- Class Antibacterials
- Mechanism of Action Membrane lipid modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Discontinued Acne
Most Recent Events
- 05 Mar 2010 Phase-I clinical trials in Acne in USA (Topical)